Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Oscar Lambret Center, Lille
Frequently Asked Questions Orforglipron (LY3502970) is an investigational oral, non-peptide, small-molecule GLP-1 receptor agonist developed by Eli Lilly
Under refrigerated conditions, the reconstituted solution is typically stable for a limited period (often 1-2 weeks for many compounded peptides, though some preparations may remain stable up to 28 days or longer
Some commonly noted benefits include: Reduced redness and swelling around active breakouts Faster healing of acne lesions with less scarring Improved skin texture and tone Fading of post-acne marks and hyperpigmentation By targeting the underlying causes of acne such as inflammation, bacterial imbalance, and slow healing Glow Up Copper Peptide Patches provide a comprehensive solution for clearer, healthier skin
